“Canadian molecular diagnostics firm Spartan Biosciences this week unveiled the Spartan RX, a fully automated, point-of-care, PCR-based testing platform for personalized medicine.”
“Vying to break into the point-of-care testing market to guide anti-platelet treatment in cardiac patients, at least two molecular diagnostics companies are studying the utility of their rapid tests in clinical trials.”
“Spartan Bioscience…reported the availability of the Spartan RX, the first complete sample-to-result, point-of-care DNA testing system for personalized medicine.”
“Spartan Bioscience Inc. of Ottawa is one of 18 Canadian companies to share $40 million in funding from Sustainable Development Technology Canada, a federally-funded investor in new clean technology.”
“Dr. Paul Lem was recently honoured with the Premier’s 2010 award for best young innovator in Ontario for the development of the world’s first desktop DNA analyzer.”
“You might say success seems to be in the genes of an Ottawa firm. Spartan Bioscience designed the world’s first desktop device to analyze DNA.”
“Spartan Bioscience said today that it will work with Cooperative Diagnostics to validate the use of an HIV assay on its analyzer as part of an effort to develop an HIV test for developing countries.”
“Canadian molecular diagnostics firm Spartan Bioscience said today that it will collaborate with Norwegian firm NorDiag on the development of an end-to-end DNA sample preparation and analysis system.”
“Spartan Bioscience of Ottawa was recognized by the UK-based consulting firm Frost & Sullivan and received the Global Polymerase Chain Reaction (PCR) Product of the Year Award.”
“Under a new strategic partnership, TrimGen will develop technology for Spartan Bioscience and Spartan will distribute TrimGen products in Canada, Ottawa-based Spartan said today.”